Effect of gadolinium injection on diffusion-weighted imaging with background body signal suppression (DWIBS) imaging of breast lesions

Magnetic Resonance Imaging

Volumn 32, Issue 10, 2014, Pages 1242-1246

  Moschetta, Marco ^a   Telegrafo, Michele ^a   Rella, Leonarda ^a   Stabile Ianora, Amato Antonio ^a   Angelelli, Giuseppe ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

Author keywords

Breast; Diffusion; Dwibs; Gadolinium; MRI

Indexed keywords

GADOBENATE DIMEGLUMINE;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; BREAST FIBROADENOLIPOMA; BREAST FIBROADENOMA; BREAST FIBROSIS; BREAST HYPERPLASIA; BREAST LESION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DIFFUSION WEIGHTED IMAGING WITH BACKGROUND BODY SIGNAL SUPPRESSION IMAGING; FALSE POSITIVE RESULT; GOLD STANDARD; HISTOLOGY; HUMAN; INTERMETHOD COMPARISON; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE SCANNER; PREDICTIVE VALUE; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

NUCLEOPOLYHEDROVIRUS;

EID: 85027946875     PISSN: 0730725X     EISSN: 18735894     Source Type: Journal    
DOI: 10.1016/j.mri.2014.07.014     Document Type: Article

References (36)

1. Koh D.M., Collins D.J. Diffusion weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 2007, 188:1622-1635.
2. Thoeny H.C., De Keyzer F. Extracranial applications of diffusion-weighted magnetic resonance imaging. Eur Radiol 2007, 17:1385-1393.
3. Tamai K., Koyama T., Saga T., Umeoka S., Mikami Y., Fujii S., et al. Diffusion weighted MR imaging of uterine endometrial cancer. J Magn Reson Imaging 2007, 26:682-687.
4. Tamai K., Koyama T., Saga T., Morisawa N., Fujimoto K., Mikami Y., et al. The utility of diffusion weighted MR imaging for differentiating uterine sarcomas from benign leiomyomas. Eur Radiol 2008, 18:723-730.
5. Ichikawa T., Erturk S.M., Motosugi U., Sou H., Iino H., Araki T., et al. High-B-value diffusion-weighted MRI in colorectal cancer. AJR Am J Roentgenol 2006, 187:181-184.
6. Kwee T.C., Takahara T., Ochiai R., Nievelstein R.A., Luijten P.R. Diffusion-weighted wholebody imaging with background body signal suppression (DWIBS): features and potential applications in oncology. Eur Radiol 2008, 18:1937-1952.
7. Heywang-Kobrunner S.H. Contrast-enhanced magnetic resonance imaging of the breast. Invest Radiol 1994, 29:94-104.
8. Orel S.G., Schnall M.D., Livolsi V.A., Troupin R.H. Suspicious breast lesions: MR imaging with radiologic-pathologic correlation. Radiology 1994, 190:485-493.
9. Huang W., Fisher P.R., Dulaimy K., Tudorica L.A., O'Hea B., Button T.M. Detection of breast malignancy: diagnostic MR protocol for improved specificity. Radiology 2004, 232:585-591.
10. Kuhl C.K. MRI of breast tumors. Eur Radiol 2000, 10:46-58.
11. Baum F., Fischer U., Vosshenrich R., Grabbe E. Classification of hypervascularized lesions in CE MR imaging of the breast. Eur Radiol 2002, 12:1087-1092.
12. Hoffmann U., Brix G., Knopp M.V., Hess T., Lorenz W.J. Pharmacokinetic mapping of the breast: a new method for dynamic MR mammography. Magn Reson Med 1995, 33:506-514.
13. Kuhl C.K., Mielcareck P., Klaschik S., Leutner C., Wardelmann E., Gieseke J., et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?. Radiology 1999, 211:101-110.
14. Degani H., Gusis V., Weinstein D., Fields S., Strano S. Mapping pathophysiological features of breast tumors by MRI at high spatial resolution. Nat Med 1997, 3:780-782.
15. Orel S.G. High-resolution MR, imaging for the detection, diagnosis, and staging of breast cancer. Radiographics 1998, 18:903-912.
16. Vestito A., Mangieri F.F., Gatta G., Moschetta M., Turi B., Ancona A. Breast carcinoma in elderly women. Our experience. G Chir 2011, 32:411-416.
17. Belli P., Costantini M., Bufi E., Magistrelli A., La Torre G., Bonomo L. Diffusion weighted imaging in breast lesion evaluation. Radiol Med 2010, 115:51-69.
18. Peters N.H., Borel Rinkes I.H., Zuithoff N.P., Mali W.P., Moons K.G., Peeters P.H. Meta-analysis of MR imaging in the diagnosis of breast lesions. Radiology 2008, 246:116-124.
19. Kul S., Cansu A., Alhan E., Dinc H., Gunes G., Reis A. Contribution of diffusion-weighted imaging to dynamic contrast-enhanced MRI in the characterization of breast tumors. AJR Am J Roentgenol 2011, 196:210-217.
20. Moschetta M., Telegrafo M., Rella L., Capolongo A., Stabile Ianora A.A., Angelelli G. MR evaluation of breast lesions obtained by diffusion-weighted imaging with background body signal suppression (DWIBS) and correlations with histological findings. Magn Reson Imaging 2014, 10.1016/j.mri.2014.03.009.
21. Stadlbauer A., Bernt R., Gruber S., Bogner W., Pinker K., van der Riet W., et al. Diffusion-weighted MR imaging with background body signal suppression (DWIBS) for the diagnosis of malignant and benign breast lesions. Eur Radiol 2009, 19:2349-2356.
22. Janka R., Hammon M., Geppert C., Nothhelfer A., Uder M., Wenkel E. Diffusion-weighted MR imaging of benign and malignant breast lesions before and after contrast enhancement. Rofo 2014, 186(2):130-135. 10.1055/s-0033-1350298.
23. Pediconi F., Catalano C., Occhiato R., Venditti F., Fraioli F., Napoli A., et al. Breast lesion detection and characterization at contrast-enhanced MR mammography: Gadobenate Dimeglumine versus Gadopentat Dimeglumine. Radiology 2005, 237:45-56.
24. Chiu F.Y., Jao J.C., Chen C.Y., Liu G.C., Jaw T.S., Chiou Y.Y., et al. Effect of intravenous gadolinium-DTPA on diffusion-weighted magnetic resonance images for evaluation of focal hepatic lesions. J Comput Assist Tomogr 2005, 29:176-180.
25. Benndorf M., Schelhorn J., Dietzel M., Kaiser W.A., Baltzer P.A. Diffusion weighted imaging of liver lesions suspect for metastases: Apparent diffusion coefficient (ADC) values and lesion contrast are independent from Gd-EOB-DTPA administration. Eur J Radiol 2012, 81:e849-e853.
26. Liu K. The effect of gadolinium chelate contrast agent on diffusion-weighted imaging of pancreatic ductal adenocarcinoma. Acta Radiol 2013, 10.1177/0284185112471795.
27. Wang C.L., Chea Y.W., Boll D.T., Samei E., Neville A.M., Dale B.M., et al. Effect of gadolinium chelate contrast agents on diffusion weighted MR imaging of the liver, spleen, pancreas and kidney at 3T. Eur J Radiol 2011, 80(2):e1-e7. 10.1016/j.ejrad.2010.05.019.
28. Kiselev V.G. Effect of magnetic field gradients induced by microvasculature on NMR measurements of molecular self-diffusion in biological tissues. J Magn Reson 2004, 170(2):228-235.
29. Kennan R.P., Zhong J., Gore J.C. On the relative importance of paramagnetic relaxation and diffusion-mediated susceptibility losses in tissues. Magn Reson Med 1991, 22(2):197-203.
30. Thomassin-Naggara I., De Bazelaire C., Chopier J., Bazot M., Marsault C., Trop I. Diffusion-weighted MR imaging of the breast: advantages and pitfalls. Eur J Radiol 2013, 82(3):435-443.
31. Chen G., Jespersen S.N., Pedersen M., Pang Q., Horsman M.R., Stodkilde-Jorgensen H. Intravenous administration of Gd-DTPA prior to DWI does not affect the apparent diffusion constant. Magn Reson Imaging 2005, 23:685-689.
32. Rubesova E., Grell A.S., De Maertelaer V., Metens T., Chao S.L., Lemort M. Quantitative diffusion imaging in breast cancer: a clinical prospective study. J Magn Reson Imaging 2006, 24:319-324.
33. Hatakenaka M., Soeda H., Yabuuchi H., Matsuo Y., Kamitani T., Oda Y., et al. Apparent diffusion coefficients of breast tumors: clinical application. Magn Reson Med Sci 2008, 7:23-29.
34. Partridge S.C., DeMartini W.B., Kurland B.F., Eby P.R., White S.W., Lehman C.D. Quantitative diffusionweighted imaging as an adjunct to conventional breast MRI for improved positive predictive value. AJR Am J Roentgenol 2009, 193:1716-1722.
35. Woodhams R., Matsunaga K., Iwabuchi K., Kan S., Hata H., Kuranami M., et al. Diffusion-weighted imaging of malignant breast tumors: the usefulness of apparent diffusion coefficient (ADC) value and ADC map for the detection of malignant breast tumors and evaluation of cancer extension. J Comput Assist Tomogr 2005, 29:644-649.
36. Woodhams R., Matsunaga K., Kan S., Hata H., Ozaki M., Iwabuchi K., et al. ADC mapping of benign and malignant breast tumors. Magn Reson Med Sci 2005, 4:35-42.